http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101644778-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-84 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 |
filingDate | 2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101644778-B1 |
titleOfInvention | 1,2-Naphthoquinone-based Derivatives and and Methods for Preparing them |
abstract | The present invention relates to a compound represented by the following formula (1), a pharmaceutically acceptable salt, a hydrate, a solvate, a prodrug, a tautomer, an enantiomer or a pharmaceutically acceptable diastereomer thereof, And a pharmaceutical composition having a therapeutic or preventive effect for a metabolic disease containing the same. (One) Wherein R 1 to R 3 and X 1 to X 4 are as defined in claim 1. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102247694-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200137674-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022010322-A1 |
priorityDate | 2013-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 239.